ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,958,274 | -36.3% | 2,377,665 | -21.5% | 12.23% | -10.9% |
| Q2 2023 | $20,334,212 | -24.0% | 3,030,434 | 0.0% | 13.72% | -22.4% |
| Q1 2023 | $26,758,732 | +15.6% | 3,030,434 | 0.0% | 17.69% | +13.8% |
| Q4 2022 | $23,152,516 | -9.7% | 3,030,434 | -15.8% | 15.55% | +50.3% |
| Q3 2022 | $25,635,000 | +1.5% | 3,600,434 | +15.4% | 10.35% | -24.5% |
| Q2 2022 | $25,244,000 | +149.1% | 3,120,434 | +1139.8% | 13.71% | +176.9% |
| Q1 2021 | $10,133,000 | -58.8% | 251,695 | -39.5% | 4.95% | -32.5% |
| Q4 2020 | $24,609,000 | – | 416,200 | – | 7.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |